OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 716
Closed Access | Times Cited: 54
Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 716
Closed Access | Times Cited: 54
Showing 26-50 of 54 citing articles:
Nanomedicine as a Potential Tool against Monkeypox
Nura A. Mohamed, Luisa Zupin, Sarah Ismail Mazi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 428-428
Open Access | Times Cited: 10
Nura A. Mohamed, Luisa Zupin, Sarah Ismail Mazi, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 428-428
Open Access | Times Cited: 10
Neutralization Determinants on Poxviruses
Riccardo Vernuccio, Pablo Guardado‐Calvo
Viruses (2023) Vol. 15, Iss. 12, pp. 2396-2396
Open Access | Times Cited: 10
Riccardo Vernuccio, Pablo Guardado‐Calvo
Viruses (2023) Vol. 15, Iss. 12, pp. 2396-2396
Open Access | Times Cited: 10
Rapid and highly potent humoral responses to mpox nanovaccine candidates adjuvanted by thermostable scaffolds
Haozhen Yan, Yuanli Peng, Jinsong Zhang, et al.
Vaccine (2024) Vol. 42, Iss. 8, pp. 2072-2080
Closed Access | Times Cited: 3
Haozhen Yan, Yuanli Peng, Jinsong Zhang, et al.
Vaccine (2024) Vol. 42, Iss. 8, pp. 2072-2080
Closed Access | Times Cited: 3
Evaluation of a Multiplexed Immunoassay for Assessing Long-Term Humoral Immunity to Monkeypox virus infection and Orthopoxvirus Vaccination
Bethany Hicks, Scott Jones, Helen Callaby, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Bethany Hicks, Scott Jones, Helen Callaby, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings
Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126409-126409
Open Access | Times Cited: 3
Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126409-126409
Open Access | Times Cited: 3
The Durability and Avidity of MPXV-specific Antibodies Induced by the Two-dose MVA-BN Mpox Vaccine
Aaron L. Oom, Angelica C Kottkamp, Kesi K Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Aaron L. Oom, Angelica C Kottkamp, Kesi K Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens
Shuo Song, Zuning Ren, Jiayin Chen, et al.
Immunologic Research (2024)
Closed Access | Times Cited: 2
Shuo Song, Zuning Ren, Jiayin Chen, et al.
Immunologic Research (2024)
Closed Access | Times Cited: 2
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine
Meredith B. Finn, Thomas A. Penfound, Sanaz Salehi, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126205-126205
Closed Access | Times Cited: 2
Meredith B. Finn, Thomas A. Penfound, Sanaz Salehi, et al.
Vaccine (2024) Vol. 42, Iss. 22, pp. 126205-126205
Closed Access | Times Cited: 2
Advancements in monkeypox vaccines development: a critical review of emerging technologies
Igor Garcia-Atutxa, Paul Mondragón‐Terán, Alejandro Huerta‐Saquero, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Igor Garcia-Atutxa, Paul Mondragón‐Terán, Alejandro Huerta‐Saquero, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Single-chain A35R-M1R-B6R trivalent mRNA vaccines protect mice against both mpox virus and vaccinia virus
Tianxiang Kong, Pei Du, Renyi Ma, et al.
EBioMedicine (2024) Vol. 109, pp. 105392-105392
Closed Access | Times Cited: 2
Tianxiang Kong, Pei Du, Renyi Ma, et al.
EBioMedicine (2024) Vol. 109, pp. 105392-105392
Closed Access | Times Cited: 2
Longitudinal viral shedding and antibody response characteristics of men with acute infection of monkeypox virus: a prospective cohort study
Yang Yang, Liuqing Yang, Shuo Song, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Yang Yang, Liuqing Yang, Shuo Song, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
MpoxPlex: a high-throughput and versatile multiplexed immunoassay for assessing and discriminating between IgG responses to Mpox infection and vaccination
Scott Jones, Bethany Hicks, Helen Callaby, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Scott Jones, Bethany Hicks, Helen Callaby, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A Pseudovirus Nanoparticle Displaying the Vaccinia Virus L1 Protein Elicited High Neutralizing Antibody Titers and Provided Complete Protection to Mice against Mortality Caused by a Vaccinia Virus Challenge
Pengwei Huang, Ming Xia, Frank S. Vago, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 846-846
Open Access | Times Cited: 1
Pengwei Huang, Ming Xia, Frank S. Vago, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 846-846
Open Access | Times Cited: 1
Mpox treatment evolution: past milestones, present advances, and future directions
Alagammai Ganesan, Thirumalai Arunagiri, Suganandhini Mani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
Alagammai Ganesan, Thirumalai Arunagiri, Suganandhini Mani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1
An overview of the progress made in research into the Mpox virus
Yansheng Li, Lianrong Wang, Shi Chen
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 1
Yansheng Li, Lianrong Wang, Shi Chen
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 1
Viral infection and antiviral immunity in the oral cavity
Heather D. Hickman, Niki M. Moutsopoulos
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 1
Heather D. Hickman, Niki M. Moutsopoulos
Nature reviews. Immunology (2024)
Closed Access | Times Cited: 1
Next-generation mpox vaccines: efficacy of mRNA-1769 compared to modified vaccinia virus Ankara in non-human primates
Leonie Mayer, Leonie M. Weskamm, Marylyn M. Addo
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Leonie Mayer, Leonie M. Weskamm, Marylyn M. Addo
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Analysis of binding and authentic virus-neutralizing activities of immune sera induced by various monkeypox virus antigens
Shuo Song, Zuning Ren, Jiayin Chen, et al.
Research Square (Research Square) (2024)
Open Access
Shuo Song, Zuning Ren, Jiayin Chen, et al.
Research Square (Research Square) (2024)
Open Access
When ASFV Infection Meets the cGAS-STING Signaling Pathway
Songbiao Chen, Ke Shang, Ying Wei, et al.
Transboundary and Emerging Diseases (2024) Vol. 2024, pp. 1-16
Open Access
Songbiao Chen, Ke Shang, Ying Wei, et al.
Transboundary and Emerging Diseases (2024) Vol. 2024, pp. 1-16
Open Access
A Penta-Component Mpox mRNA Vaccine Induced Protective Immunity in Naive and Simian Immunodeficiency Virus Infected Nonhuman Primates
Cheng‐Feng Qin, Qing Ye, Dong Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Cheng‐Feng Qin, Qing Ye, Dong Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Understanding emerging and re-emerging viruses to facilitate pandemic preparedness
Francisco J. Zapatero‐Belinchón, Priti Kumar, Mélanie Ott, et al.
Nature Microbiology (2024) Vol. 9, Iss. 9, pp. 2208-2211
Closed Access
Francisco J. Zapatero‐Belinchón, Priti Kumar, Mélanie Ott, et al.
Nature Microbiology (2024) Vol. 9, Iss. 9, pp. 2208-2211
Closed Access
Rapid Decline of Mpox Antibody Responses Following MVA-BN Vaccination
Ai‐ris Y. Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Ai‐ris Y. Collier, Katherine McMahan, Catherine Jacob-Dolan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of Inoculation
Catherine A. Cotter, Maxinne A. Ignacio, Jeffrey L. Americo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Catherine A. Cotter, Maxinne A. Ignacio, Jeffrey L. Americo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
Antonia Radaelli, Carlo Zanotto, C.I. Brambilla, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access
Antonia Radaelli, Carlo Zanotto, C.I. Brambilla, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access
A penta-component mpox mRNA vaccine induces protective immunity in nonhuman primates
Qing Ye, Dong Zhang, Rongrong Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Qing Ye, Dong Zhang, Rongrong Zhang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
